Search
for
Sort by
Research 571–600 of 1000+
- Lysophospholipid Mediators in Health and Disease
- Critical Analysis on Characterization, Systemic Effect, and Therapeutic Potential of Beta-Sitosterol: A Plant-Derived Orphan Phytosterol
- Immune-Epithelial Cross Talk in Regeneration and Repair
- Eco-innovation in action: valorizing vegetable waste into high-value ingredients for sustainable applications
- Development of a Carvedilol-Loaded Solid Self-Nanoemulsifying System with Increased Solubility and Bioavailability Using Mesoporous Silica Nanoparticles
- Chitosan Nanoparticle-Encapsulated Cordyceps militaris Grown on Germinated Rhynchosia nulubilis Reduces Type II Alveolar Epithelial Cell Apoptosis in PM2.5-Induced Lung Injury
- Application of microneedle patches for drug delivery; doorstep to novel therapies
- From Diospyros kaki L. (Persimmon) Phytochemical Profile and Health Impact to New Product Perspectives and Waste Valorization
- Freeze-Drying of Platelet-Rich Plasma: The Quest for Standardization
- Hair growth potential of <i>Salvia plebeia</i> extract and its associated mechanisms
- Turmeric Essential Oil Constituents as Potential Drug Candidates: A Comprehensive Overview of Their Individual Bioactivities
- Probiotics in Dermatology: An Evidence-based Approach
- Potential of Colostrum-Derived Exosomes for Promoting Hair Regeneration Through the Transition From Telogen to Anagen Phase
- Essential Oils and Melatonin as Functional Ingredients in Dogs
- Lactic Acid Bacteria as Probiotics Improve Bioactive Compounds in Radix Angelica gigas (Danggui) via Solid-State Fermentation
- A review on formulation and analytical aspect of mangiferin a natural phenolic xanthonoid
- Progress in the design of ascorbic acid derivative-mediated drug delivery
- H3K9me3 controls epidermis morphogenesis by regulating RNA Pol II dynamics at developmental promoters and enhancers
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- The Global Grind: Past Trends and Future Brews of the Coffee Culture
- A methodological exploration of distinguishing hair quality based on hair proteomics
- Insights on the Hair Keratin Structure Under Different Drying Conditions
- Vitiligo - Part 2 - classification, histopathology and treatment
- Current and prospective strategies for advancing the targeted delivery of CRISPR/Cas system via extracellular vesicles
- Cell Membrane-Camouflaged Nanoparticles Mediated Nucleic Acids Delivery
- Densitometry and Video-microscopy
- Crystallin Fusion Proteins Improve the Thermal Properties of Hair
- Preparation and evaluation of minoxidil foamable emu oil emulsion.
- Activated Platelet Rich Plasma versus Non-Activated Platelet Rich Plasma in the Treatment of Alopecia Areata